Sinopia Biosciences Overview

  • Founded
  • 2014
  • Status
  • Private
  • Employees
  • 3
  • Latest Deal Type
  • Grant
  • (Announced)
  • Latest Deal Amount
  • $500K
Latest Deal Amount
  • Investors
  • 3

Sinopia Biosciences General Information


Developer of a bioinformatics platform designed for drug discovery and repurposing. The company's platform uses proprietary machine learning for drug repurposing to identify therapeutics that reduce adverse drug reactions of life-changing medications with a lead compound in Parkinson's Disease, enabling doctors to identify pathways that are implicated in causing Parkinson's Disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Primary Office
  • 3210 Merryfield Row
  • San Diego, CA 92121
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sinopia Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 01-Jan-2020 $500K Announced Pre-Clinical Trials
3. Accelerator/Incubator 26-Mar-2018 Completed Clinical Trials - Phase 1
2. Grant 01-Jan-2016 $5.8M Completed Pre-Clinical Trials
1. Grant 01-Aug-2015 $224K Completed Pre-Clinical Trials
To view Sinopia Biosciences’s complete valuation and funding history, request access »

Sinopia Biosciences Executive Team (4)

Name Title Board Seat Contact Info
Iman Famili Ph.D President & Chief Executive Officer
Aarash Bordbar Co-Founder, Chief Technology Officer & Chief Financial Officer
Bernhard Palsson Ph.D Co-Founder & Board Member
Tanya Simuni MD Acting Chief Medical Officer & Scientific Advisory Board
To view Sinopia Biosciences’s complete executive team members history, request access »

Sinopia Biosciences Board Members (3)

Name Representing Role Since
Abhay Joshi Sinopia Biosciences Chairman 000 0000
Bernhard Palsson Ph.D Sinopia Biosciences Co-Founder & Board Member 000 0000
Tanya Simuni MD Sinopia Biosciences Acting Chief Medical Officer & Scientific Advisory Board 000 0000
To view Sinopia Biosciences’s complete board members history, request access »

Sinopia Biosciences Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sinopia Biosciences Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
JLABS Accelerator/Incubator 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Michael J. Fox Foundation Limited Partner 000 0000 000000 0
To view Sinopia Biosciences’s complete investors history, request access »